Pluristem Therapeutic Revenue (Quarterly YoY Growth):-51.28% for Dec. 31, 2013
View 4,000+ financial data types
Pluristem Therapeutic Revenue (Quarterly YoY Growth) Chart
Pluristem Therapeutic Historical Revenue (Quarterly YoY Growth) DataPro Export Data Date Range:
|Data for this Date Range|
|Dec. 31, 2013||-51.28%|
|Sept. 30, 2013||-51.28%|
|June 30, 2013||-5.94%|
|March 31, 2013||-15.65%|
|Dec. 31, 2012||-15.58%|
|Sept. 30, 2012||26.62%|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
PSTI Revenue (Quarterly YoY Growth) Benchmarks
PSTI Revenue (Quarterly YoY Growth) Range, Past 5 Years
GlobeNewswire 03/06 03:00 ET
Yahoo 02/26 10:29 ET
Yahoo 02/24 16:50 ET
Zacks 02/24 11:50 ET
Yahoo 02/20 05:43 ET
GlobeNewswire 02/20 03:00 ET
Yahoo 02/18 05:44 ET
GlobeNewswire 02/18 03:00 ET
GlobeNewswire 02/13 03:00 ET